title: Fluoride therapy in postmenopausal osteopenic women: effect on vertebral and femoral bone density and prediction of bone response.
abstract: Fifty-two postmenopausal women (mean age 60 +/- 5 years) with low BMD (less than -2SD of young adult values) but who had not experienced previous crush fracture were treated with 50 mg of sodium fluoride (NaF), 1 g of calcium and 400 IU of vitamin D2 per day for 2 years. Repeated vertebral and femoral BMD measurements were made and compared with those of a control group consisting of 16 untreated women. Serum alkaline phosphatase and osteocalcin, blood and urinary fluoride levels were measured regularly to determine their predictive value on bone response. 18 of 52 (35%) of the treated patients experienced side effects (29% gastric, 4% lower extremity pain syndrome) but only in 6 cases (12%) was it necessary to discontinue treatment. In neither of the two groups was any fracture recorded (vertebral or otherwise). Among the 43 women who were treated for at least 2 years, 21 (49%) were considered to have responded (i.e., with an increase of vertebral BMD greater than 0.043 g/cm2). There was a mean linear increase in BMD in this group of 0.0041 g/cm2 per month (i.e., 5.5% per year). On the other hand in the non-responder group and in the control group, vertebral BMD either remained stable or decreased. However no difference was detected between the two groups (treated and controls) at the femoral site after 2 years; both groups showed a significant decrease in BMD. The responders had a lower initial osteocalcin level and treatment led to a relatively greater increase in osteocalcin.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Service d'Endocrinologie, U.F. Maladies Osseuses et Métaboliques, Toulouse, France.
authors.forename: J M
authors.initials: JM
authors.lastname: Pouilles
authors.forename: F
authors.initials: F
authors.lastname: Tremollieres
authors.forename: E
authors.initials: E
authors.lastname: Causse
authors.forename: J P
authors.initials: JP
authors.lastname: Louvet
authors.forename: C
authors.initials: C
authors.lastname: Ribot
mesh_terms: D000368:Aged; D015519:Bone Density / Q000187:drug effects*; D005260:Female; D005269:Femur / Q000187:drug effects*; D006801:Humans; D008159:Lumbar Vertebrae / Q000187:drug effects*; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D012969:Sodium Fluoride / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D012969:Sodium Fluoride